KURE

KraneShares$15.24+0.29 (+1.95%)
AUM $68.9MER 0.79%NAV $15.14Holdings 53

Price Chart

Key Statistics

Previous Close

$14.95

Day Range

$15.13$15.26

52-Week Range

$14.52$21.84

Avg Volume

26.3K

Dividend Yield

4.22%

Expense Ratio

0.79%

AUM

$68.9M

Shares Outstanding

4.6M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare99.31%
Consumer Defensive0.69%

Country Allocation

CountryWeight %
China87.84%
Switzerland9.27%
United States1.46%
Other1.44%

Fund Information

Category
Healthcare
Types
China
Inception Date
Jan 31, 2018
Exchange
NYSE_ARCA
Description
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$38.75B
VHTVanguard Health Care ETF$18.50B
COWZPacer US Cash Cows 100 ETF$18.42B
RWLInvesco S&P 500 Revenue ETF$9.16B
XBIState Street SPDR S&P Biotech ETF$8.07B

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund issued by KraneShares that launched on Jan 31, 2018. It currently manages $68.9M in assets under management. The fund charges an expense ratio of 0.79%. The fund holds 53 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 55.3% of the fund

RankSymbolNameWeight %SharesMarket Value
16160.HKBEONE MEDICINES LTD-H9.27%297,918$6.4M
21801.HKINNOVENT BIOLOGICS INC8.40%593,500$5.8M
32269.HKWUXI BIOLOGICS CAYMAN INC7.94%1,322,635$5.5M
4603259.SSWUXI APPTEC CO LTD-A5.76%277,720$4.0M
5300760.SZSHENZHEN MINDRAY BIO-MEDIC-A4.36%142,855$3.0M
6600276.SSJIANGSU HENGRUI PHARMACEUT-A4.33%433,708$3.0M
79926.HKAKESO INC4.24%230,000$2.9M
81093.HKCSPC PHARMACEUTICAL GROUP LT3.90%2,908,889$2.7M
91177.HKSINO BIOPHARMACEUTICAL3.55%4,078,750$2.4M
102359.HKWUXI APPTEC CO LTD-H3.52%153,684$2.4M
113692.HKHANSOH PHARMACEUTICAL GROUP2.83%512,000$1.9M
12688271.SSSHANGHAI UNITED IMAGING HE-A2.45%102,398$1.7M
131530.HK3SBIO INC2.33%788,500$1.6M
14000538.SZYUNNAN BAIYAO GROUP CO LTD-A2.31%221,723$1.6M
15300015.SZAIER EYE HOSPITAL GROUP CO-A2.11%1,158,663$1.5M
Page 1 of 2

Detailed Returns

PeriodReturnETF
1D
+1.95%
1W
+0.18%
1M
-12.34%
3M
-10.03%
6M
-15.98%
YTD
-12.26%
1Y
-15.14%
3Y
-19.29%
5Y
-65.84%

Moving Averages

20-Day MA

$15.66

Below 20-Day MA
50-Day MA

$16.80

Below 50-Day MA
200-Day MA

$18.34

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$21.84

Current Price

$15.24

52-Week Low

$14.52

$14.52$21.84

Current Yield

4.22%

Annual Dividend

$1.0215

Frequency

1x/year

Last Ex-Date

Dec 22, 2025

Dividend History

Ex-DateAmountPay Date
Dec 22, 2025$0.7147Dec 23, 2025
Dec 17, 2024$0.1836Dec 18, 2024
Dec 18, 2023$0.1128Dec 20, 2023
Dec 28, 2022$0.0104Dec 30, 2022
Dec 29, 2021$4.0535Dec 31, 2021
Dec 29, 2020$0.0001Dec 31, 2020
Dec 27, 2019$0.0573Dec 31, 2019
Dec 26, 2018$0.0393Dec 28, 2018
Dec 26, 2018$0.0366Dec 28, 2018

Dividend Payments Over Time

Category Comparison

MetricKUREHealthcare(174 ETFs)China(122 ETFs)
Fund Info
Expense Ratio0.79%0.60%0.77%
AUM$68.9M$875.8M$1.95B
Dividend Yield4.22%3.42%3.78%
Avg Volume26.3K270.2K734.9K
Holdings5389216
Performance
1-Month Return-13.56%+2.02%-2.76%
6-Month Return-19.78%+3.84%+3.97%
YTD Return-12.29%+3.23%+6.55%
1-Year Return-14.89%+23.91%+19.71%

Compare with Another ETF

Search for an ETF to compare with KURE:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.